← Mechanisms of action
Erythrocyte
CELL-LINE
Drugs acting on this target (11)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| betaas3-fb vector transduced bm cd34+ cells | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| biotinylated red blood cells | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| cord blood erythrocytes | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| drepaglobe | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| hix763 | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| irradiated red blood cells | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| otq923 | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| red blood cells | Supplementation | marketed | Cell therapy | Erythrocyte supplementation |
| rtx-240 | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| s303 red blood cells | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |
| wtx212 | Supplementation | experimental | Cell therapy | Erythrocyte supplementation |